Skip to main content

Lifordi Immunotherapeutics

Burlington, United States

Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and inflammatory disorders.

$42.0M raised
Nov 2025
Venture - Series Unknown

Top Investors

ARCH Venture PartnersSanofi VenturesAtlas Venture5AM Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Lifordi Immunotherapeutics

How much funding has Lifordi Immunotherapeutics raised?
Lifordi Immunotherapeutics has raised $42.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
Who are Lifordi Immunotherapeutics's investors?
Lifordi Immunotherapeutics's investors include ARCH Venture Partners, Sanofi Ventures, Atlas Venture, 5AM Ventures.
Where is Lifordi Immunotherapeutics headquartered?
Lifordi Immunotherapeutics is headquartered in Burlington, United States.
What does Lifordi Immunotherapeutics do?
Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and inflammatory disorders.
What stage is Lifordi Immunotherapeutics at?
Lifordi Immunotherapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Lifordi Immunotherapeutics — Funding & Investors." VCBacked, November 19, 2025, https://www.vcbacked.co/company/lifordi-immunotherapeutics. Accessed June 4, 2026.
APA
VCBacked. (2025). Lifordi Immunotherapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/lifordi-immunotherapeutics
Wikipedia (cite web)
{{cite web |title=Lifordi Immunotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/lifordi-immunotherapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .